about
Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertensionEthanol consumption increases blood pressure and alters the responsiveness of the mesenteric vasculature in ratsBig endothelin-1 and nitric oxide in hypertensive elderly patients with and without obstructive sleep apnea-hypopnea syndrome.Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteersRelationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patientsEnantioselectivity in the pharmacokinetic interaction between fluvastatin and lercanidipine in healthy volunteers.A comparison between diuretics and angiotensin-receptor blocker agents in patients with stage I hypertension (PREVER-treatment trial): study protocol for a randomized double-blind controlled trial.Prevention of hypertension in patients with pre-hypertension: protocol for the PREVER-prevention trial.Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers7th Brazilian Guideline of Arterial Hypertension: Chapter 2 - Diagnosis and ClassificationEfficacy of Propolis on the Denture Stomatitis Treatment in Older Adults: A Multicentric Randomized Trial.Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients.Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain.The Diterpene Sclareol Vascular Effect in Normotensive and Hypertensive Rats.Prolonged viability of human organotypic skin explant in culture method (hOSEC).Effect of the Copaifera langsdorffii Desf. Leaf Extract on the Ethylene Glycol-Induced Nephrolithiasis in Rats.Enantioselective analysis of praziquantel and trans-4-hydroxypraziquantel in human plasma by chiral LC-MS/MS: Application to pharmacokinetics.Antioxidant effect of doxycycline decreases MMP activity and blood pressure in SHR.Pregnancy-associated increase in rat systemic arteries endothelial nitric oxide production diminishes vasoconstrictor but does not enhance vasodilator responses.Enantioselective determination of metoprolol acidic metabolite in plasma and urine using liquid chromatography chiral columns: applications to pharmacokinetics.Dynamic and kinetic disposition of nisoldipine enantiomers in hypertensive patients presenting with type-2 diabetes mellitus.Enantioselective determination of lercanidipine in human plasma for pharmacokinetic studies by normal-phase liquid chromatography-tandem mass spectrometry.Effects of prostanoids on phenylephrine-induced contractions in the mesenteric vascular bed of rats with streptozotocin-induced diabetes mellitus.Analysis of oxcarbazepine and the 10-hydroxycarbazepine enantiomers in plasma by LC-MS/MS: application in a pharmacokinetic study.Influence of glomerular filtration rate on the pharmacokinetics of cyclophosphamide enantiomers in patients with lupus nephritis.Influence of quinidine, cimetidine, and ketoconazole on the enantioselective pharmacokinetics and metabolism of metoprolol in rats.Influence of quinidine, fluvoxamine, and ketoconazole on the enantioselective pharmacokinetics of citalopram in rats.Enantioselective determination of mexiletine and its metabolites p-hydroxymexiletine and hydroxymethylmexiletine in rat plasma by normal-phase liquid chromatography-tandem mass spectrometry: application to pharmacokinetics.Investigation of the in vivo activity of CYP3A in Brazilian volunteers: comparison of midazolam and omeprazole as drug markers.Stereoselective analysis of metoprolol and its metabolites in rat plasma with application to oxidative metabolism.Difficulties and challenges in reviewing ethical aspects of research in Brazil.The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries.Pharmacokinetics of cyclophosphamide enantiomers in patients with breast cancer.Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects.Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers.Association of Mineralocorticoid Receptor Polymorphism I180V With Left Ventricular Hypertrophy in Resistant Hypertension.Effects of Type 2 Diabetes Mellitus in Patients on Treatment With Glibenclamide and Metformin on Carvedilol Enantiomers Metabolism.[Evaluation and incorporation of health technologies: process and methodology adopted by a high-complexity care university].Ethanol consumption alters the expression and reactivity of adrenomedullin in the rat mesenteric arterial bed.Enantioselectivity in the Metabolism of Cyclophosphamide in Patients With Multiple or Systemic Sclerosis
P50
Q28292785-07D739F6-612C-409B-98B8-2251D541D622Q28571631-0601F997-5119-43FA-BA0F-C3B20729088CQ33773357-21805DA0-03AE-4194-B609-3D11A91B2173Q34019331-CA521533-97E8-4A4C-8830-E1031A2B62A8Q34065305-8FF7DCBD-9177-4D45-ADA2-72969DFF012DQ34657726-FDC93AE0-3FBF-4766-9BCD-84F1AB6E7979Q34668757-3B2D260F-E574-48DC-84BA-70D3908C5C3BQ34686960-EF31F2D1-493A-46BB-8B0C-02BDB188D8F5Q37030741-01FA74A7-D713-46EE-A937-66B3789852ADQ37656193-CDB69288-915F-40CA-898E-73C8F06E100FQ37726955-C722844E-1818-49D3-B979-8ADA56457D9DQ38776173-858C3F0D-114E-411D-BE85-4BB7EDA3DF35Q39944445-4979A049-C37F-4AE5-9577-3AC76BACBCECQ41556553-999B5E83-A008-49B1-A4A6-66F46CA81723Q42116471-E9DB02F3-56DB-41ED-83C1-E67EFAD9F193Q42583726-6C21BF3D-BC38-4562-9CD2-1007A5006B83Q43295639-4EA752EB-3C2E-41D2-9AE3-7A9991675444Q43538572-2396F9F3-963E-4F90-985A-4C37B901FE03Q43991392-B6F8E29C-74DB-4F54-9F75-DBA18FD4E39CQ44249402-884E9CD0-3BDA-43E8-A62E-F9A1D6841989Q44250239-4FF2AA5E-97AE-401B-ACF2-10008755F608Q44633707-19FA941D-269B-4FC2-A9FE-49D1EE7E24F0Q45142717-3BF0383F-B540-4791-A12E-27CBF2FF4742Q45172659-444C40C1-4FC2-4FB0-B144-DB7D2D8DEAC0Q45958144-33EDFCB4-34EF-4141-BB8F-AF7DFEB02AB4Q46152463-6E2B2DED-621D-46C6-8366-FCF87A316C4FQ46244540-3BA9ED30-E41A-4200-BDAD-2A0793122E3AQ46273668-8EE8A27B-6E4A-4FF8-A0F9-B8BDA8067312Q46518183-91F97F10-E17C-4954-AE38-FCE3E7CA8A5AQ46609045-FF26C06D-D848-4A89-BE58-AA67C9458493Q47304996-94915A7F-D4C8-4B2E-9C4D-888A6DBBAED6Q47307174-C744DEB5-14BC-4A0E-88B6-3DD40A0CB8BCQ48290223-EFC37D73-DF95-4CF7-8DCB-25B68A32D24AQ50633476-059FC935-3AF7-4469-A9E3-4AAD83B4EBE4Q53301415-75D5CA7B-04B3-4F14-BF24-34DD855801DBQ53476197-2EE242CC-6309-4D6A-8277-91C8C8C2BB2AQ54235357-11A594C5-E6BC-4D46-996F-975306666C1EQ54261335-0AA3A212-FF46-4BEA-BB18-2116BAB0E491Q54342623-AC1DBA15-14AD-4D4C-A8DA-688CF066C729Q62537789-58A0CA57-6193-48DE-BCBC-8705BB955852
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eduardo B Coelho
@nl
Eduardo B Coelho
@sl
Eduardo B. Coelho
@en
Eduardo B. Coelho
@es
type
label
Eduardo B Coelho
@nl
Eduardo B Coelho
@sl
Eduardo B. Coelho
@en
Eduardo B. Coelho
@es
prefLabel
Eduardo B Coelho
@nl
Eduardo B Coelho
@sl
Eduardo B. Coelho
@en
Eduardo B. Coelho
@es
P106
P1153
7006029024
P21
P31
P496
0000-0003-3491-3396